Deletion of the deISGylating enzyme USP18 enhances tumour cell antigenicity and radiosensitivity. (2021)

First Author: Pinto-Fernandez A
Attributed to:  Substrate Peptidomimetic Inhibitors (SPIs) of the COP9 signalosome funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41416-020-01167-y

PubMed Identifier: 33214684

Publication URI: http://europepmc.org/abstract/MED/33214684

Type: Journal Article/Review

Volume: 124

Parent Publication: British journal of cancer

Issue: 4

ISSN: 0007-0920